IL6 and polycystic ovary syndrome: Markers like IFN-γ, CCL7, MMP-10, and IL-6 may serve as potential biomarkers or therapeutic targets, and clinicians could consider incorporating these markers into diagnostic protocols to identify PCOS patients with heightened inflammatory responses.